Picture of RetinalGenix Technologies logo

RTGN RetinalGenix Technologies Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Annual cashflow statement for RetinalGenix Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
C2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-2.18-3.91-2.09-4.32-2.43
Depreciation
Non-Cash Items0.8563.481.233.391.7
Other Non-Cash Items
Changes in Working Capital0.1560.230.4130.1890.166
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Net Change in Other Assets & Liabilities
Cash from Operating Activities-1.17-0.199-0.452-0.742-0.558
Capital Expenditures-0
Purchase of Fixed Assets
Cash from Investing Activities-0
Financing Cash Flow Items00.1090.4520.0350.019
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.170.1950.4520.7480.567
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.003-0.005-00.0060.009